Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring changes in lung artery pressure using a non-invasive method in ICU patients

Official title: Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study (PAP-EIT Study)

Run by Insel Gruppe AG, University Hospital Bern · NCT06544148 · Data updated 2026-11-12

This study is testing if a new non-invasive method called electrical impedance tomography can safely and accurately measure lung artery pressure in critically ill patients in the ICU.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment28 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern)
StatusRecruiting
StartedAugust 5, 2024
Main results expectedAugust 5, 2026
Study endsAugust 5, 2027
Registry record updatedNovember 14, 2024
Trial IDNCT06544148 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are intubated patients aged 18 and older in the ICU who require monitoring of pulmonary artery pressure.

Probably not a fit

Patients with implanted thoracic electronic devices, open lung injuries, or certain thoracic conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility of using electrical impedance tomography (EIT) to monitor changes in pulmonary artery pressure (PAP) in critically ill patients. It compares the non-invasive EIT measurements with the invasive gold-standard method of PAP measurement using a pulmonary artery catheter. The goal is to determine if EIT can provide reliable data on PAP changes without the risks associated with invasive procedures. The study focuses on intubated ICU patients who require PAP monitoring.

Why it matters

Potential benefit: If successful, this approach could provide a safer, non-invasive method for monitoring pulmonary artery pressure in critically ill patients.

How similar studies have gone: While this approach is innovative, similar studies using non-invasive methods for monitoring cardiovascular parameters have shown promise, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age ≥ 18-year-old.
* Intubated patients in the ICU with clinical decision to monitor PAP and cardiac output using a PAC.

Exclusion criteria:

* Patients with implanted or external thoracic electronic devices (e.g., pacemaker) or thoracic metal implants.
* Known pregnancy or lactating patients.
* Open lung injuries or pneumothorax.
* Open wounds, drainages, burns or rashes of the upper thorax.
* Estimated thoracic perimeter smaller than 66 cm or larger than 134 cm.
* Known allergies to wound dressings or adhesives (e.g., gel electrodes)

Where it's running

  • Inselspital Bern, Universitätsklinik für Intensivmedizin
    Bern, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Kaspar F Bachmann, MD — Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • Study coordinator: Kaspar F Bachmann, MD
  • Email: kaspar.bachmann@faculty.unibe.ch
  • Phone: +41 31 632 21 11

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.